Agilent Technologies Inc.

Last updated September 27, 2026

Organization details

Legal name
Agilent Technologies Inc.
Ownership
Public
Status
Active
SIC code
3826 — Laboratory Analytical Instruments
Jurisdiction of incorporation
Delaware
Headquarters city
Santa Clara
Headquarters state / province
California
Headquarters country
United States
Fiscal year end
October
Ticker symbol
A
Primary stock exchange
NYSE

Identifiers

SEC CIK
0001090872
EIN
77-0518772

Board of directors

Chief executives

Michael R. McMullen · CEO and President
Dates unknown
Padraig Mcdonnell · President and CEO
Dates unknown

Director election results

Annual meeting of March 18, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

9 of this board's directors also sit on 14 other boards.

Network of Agilent Technologies Inc.'s board connections Lyell Immunopharma Inc. Lyell Immunopharma Inc... Belden Inc Belden Inc Bristol-Myers Squibb Company Bristol-Myers Squibb C... Cabot Corporation Cabot Corporation DexCom Inc. DexCom Inc. Incyte Corp. Incyte Corp. Inogen Inc Inogen Inc KLA Corporation KLA Corporation PDS Biotechnology Corporation PDS Biotechnology Corp... Phathom Pharmaceuticals Inc. Phathom Pharmaceutical... Rocket Pharmaceuticals Inc. Rocket Pharmaceuticals... Sana Biotechnology Inc. Sana Biotechnology Inc... Vir Biotechnology Inc. Vir Biotechnology Inc. Voyager Therapeutics Inc. Voyager Therapeutics I... George A. Scangos George A. Scangos Glenn S. Boehnlein Glenn S. Boehnlein Hans Edgar Bishop Hans Edgar Bishop Heidi Fields Heidi Fields Judy L. Brown Judy L. Brown Michael R. McMullen Michael R. McMullen Mikael Dolsten Mikael Dolsten Otis W. Brawley Otis W. Brawley Sue H. Rataj Sue H. Rataj Agilent Technologies Inc.
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$0
0 purchases by 0 insiders
Sold, last 12 months
$3,171,111
6 sales by 3 insiders
Date Insider Transaction Shares Price Value
Sep 8, 2026 Glenn S. Boehnlein Director Grant or award +817 $146.85 $119,976
Sep 4, 2026 Mikael Dolsten Director Open-market sale −634 $151.38 $95,972
Jun 26, 2026 KIRKWOOD JONAH PREVOST Officer (Senior Vice President) Shares withheld for tax −30 $136.01 $4,080
Jun 3, 2026 Padraig Mcdonnell Director, Officer (President and CEO) Shares withheld for tax −418 $137.40 $57,433
May 29, 2026 Mikael Dolsten Director Open-market sale −1,600 $135.42 $216,672
May 19, 2026 Buckner Michael Steven Officer (Senior Vice President) Grant or award +8,872 — —
May 8, 2026 MAY SIMON Officer (Senior Vice President) Shares withheld for tax −368 $115.62 $42,548
Mar 31, 2026 Meghan Henson Officer (Senior Vice President) Shares withheld for tax −153 $113.98 $17,439
Mar 19, 2026 Sue H. Rataj Director Grant or award +2,158 $111.75 $241,157
Mar 19, 2026 Otis W. Brawley Director Grant or award +2,158 $111.75 $241,157
Mar 19, 2026 George A. Scangos Director Grant or award +2,158 $111.75 $241,157
Mar 19, 2026 Pascal Soriot Director Grant or award +2,158 $111.75 $241,157
Mar 19, 2026 Dow R. Wilson Director Grant or award +2,158 $111.75 $241,157
Mar 19, 2026 Daniel K. Podolsky Director Grant or award +2,158 $111.75 $241,157
Mar 19, 2026 Boon Hwee Koh Director Grant or award +2,158 $111.75 $241,157

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.